The aim of the present investigation was to evaluate the effect of carvacrol, administered with feed, on growth, haematology and survival tambaqui, Colossoma macropomum, infected by Aeromonas hydrophila exposed to hypoxia. Carvacrol was incorporated into fish feed at the following concentrations: 0 (control), 10, 20 and 40 g.kg−1 for 60 days. Fish fed 10 g.kg−1 of carvacrol‐enriched diet had an increase in final weight (72.68 ± 1.63) and specific growth rate (1.89 ± 0.03) and a decrease in apparent feed conversion compared (1.65 ± 0.09) with the control group. In addition, the condition factor (2.03 ± 0.04) and weight gain (49.31 ± 1.54) were also improved in animals fed 10 g.kg−1with carvacrol. RBC count, MCV, mean MCHC, LG‐PAS+, thrombocytes and lymphocytes presented no differences between treatments; however, Ht (25.6 ± 1.20) and mean MCV (224.05 ± 9.64) of the animals fed the highest carvacrol level were lower than the control animals, suggesting microcytic anaemia. Increased monocytes (6.54 ± 1.07), neutrophils (9.14 ± 0.57) and phagocytic activity (32.77%) were recorded in animals fed 10 g.kg−1 with carvacrol, in relation to the control. Glucose, cholesterol and albumin presented no changes; however, lower triglyceride values were observed in animals fed 40 g.kg−1 carvacrol‐enriched diet. Animals fed 10 g.kg−1 of carvacrol had higher plasma protein (3.31 ± 0.05) and globulin (1.97 ± 0.06) concentrations and a higher survival rate when submitted to bacterial infection. Thus, carvacrol‐enriched diet improves C. macropomum growth, haemato‐immune system, metabolism and resistance to A. hydrophila infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.